ArticleBMC emergency medicine2025
Effectiveness of VExUS scores for predicting mortality among patients followed up in the emergency department due to congestive heart failure: a prospective cross-sectional study.
Article in BMC emergency medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- ΔVExPLUs: prognostic value of integrating serial changes in VExUS score and lung ultrasound in acute decompensated heart failure.European heart journal. Imaging methods and practice · 2026Article
- Assessment of Congestion in Heart Failure Using VExUS: Current Evidence, Limitations and Clinical Perspectives.Life (Basel, Switzerland) · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
BACKGROUND/
aimCongestive Heart Failure (CHF) is a major contributor to emergency department (ED) visits and mortality. Traditional diagnostic tools may not fully capture systemic venous congestion, which is a critical factor in CHF prognosis. The Venous Excess Ultrasound Score (VExUS) is a novel ultrasonographic tool that systematically evaluates venous congestion. This study aimed to assess the effectiveness of VExUS scores in predicting 30-day mortality in patients presenting to the ED with CHF symptoms.
methodsThis was a prospective, cross-sectional study involving 47 adult patients presenting to the ED with clinical signs of CHF. Patients were assigned VExUS scores of 1, 2, or 3 based on ultrasonographic findings. Laboratory values, PV Doppler flow patterns, and diameters were recorded. Logistic regression and ROC curve analyses were conducted to evaluate the predictive value of VExUS scores and PV diameter on 30-day mortality.
resultsHigher VExUS scores were associated with increased mortality. Specifically, patients with a VExUS score of 3 had significantly higher 30-day mortality compared to those with a score of 1 (OR = 15.92, p = 0.037). A PV diameter ≥ 10 mm predicted mortality with 92.31% sensitivity. Significant correlations were also found between VExUS scores and PV Doppler findings, PV diameter, and other ultrasonographic parameters.
conclusionHigher VExUS scores appear to be associated with increased 30-day mortality in CHF patients presenting to the emergency department, supporting its potential utility as a noninvasive prognostic tool. Its integration into routine ED assessment may help support risk stratification and guide more targeted management strategies. CLINICAL TRIAL NUMBER: Not applicable.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.